Opinion|Videos|August 20, 2024
Patient Education, Provider Education, and Overall Final Thoughts
In this discussion, panelists offer their final thoughts.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM
3
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
4
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
5